NutriBand Inc. (NTRB) stock analysis

P/E against its history

Not enough price and earnings history to compare.

P/E against the industry

Needs positive earnings and enough profitable companies in the industry.

EV/EBITDA against its history

Needs positive EBITDA and price history.

P/B above the industry

NutriBand's price-to-book of 13.55 is above the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

Trading above fair value

The share price of $5.94 is above our fair value estimate of $1.71.

Margin of safety under 20%

The price is 247% above fair value, so there is no margin of safety.

Revenue growing under 10% a year

Revenue grew -0.7% a year over the last three fiscal years, short of the 10% we look for.

EPS growth over 3 years

Needs positive EPS three years ago and today.

Earnings acceleration

Needs positive net income now, a year ago and five years ago.

Growing slower than the industry

Revenue grew -37.3% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

Company guidance

No outlook found in earnings releases from the last twelve months.

Gross margin slipping

Gross margin was 33.1% over the last twelve months, against 34.4% a year earlier.

Return on equity under 15%

Return on equity was -101% over the last twelve months and averaged -94.1% over five years; we look for 15% on both.

Return on capital under 10%

Return on invested capital was -320%, below the 10% that usually covers the cost of capital.

Return on equity below the industry

NutriBand's return on equity of -101% is below the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

Earnings over 5 years

Needs positive net income five years ago and in the latest year.

Net margin below its 5-year average

Net margin was -430% over the last twelve months, against a 5-year average of -361%.

Net margin below the industry

NutriBand's net margin of -430% is below the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

Low debt

Debt is 0.5% of shareholders' equity, under the 40% we consider low.

Debt falling against equity

Debt to equity fell from 2.1% five years ago to 0.5%.

Debt not well covered by cash flow

Operating cash flow over the last twelve months equals -14472% of total debt; we look for at least 20%.

Interest not well covered

Operating income covers interest expense -339.3 times; we look for at least 5.

Short-term assets cover short-term debts

Current assets are 4.21 times current liabilities.

Low bankruptcy risk

The Altman Z-score is 31.18; above 3 is the safe zone and below 1.8 the distress zone.

No dividend

NutriBand has not paid a dividend in the last twelve months.

Yield against Treasuries

No dividend.

Yield against the market

No dividend.

Dividend stability

No dividend.

Earnings cover

No dividend.

Cash-flow cover

No dividend.